Richard E. Dixon, M.D., and David J. Sencer, M.D., M.P.H.

Dr. Sencer is a former Director of the Federal Centers for Disease Control and Prevention (CDC) and Dr. Dixon is the former head of CDC's Hospital Infections Branch. Neither is currently affiliated with CDC.

Drs. Sencer and Dixon report no commercial conflicts of interest.

Disclaimer: Drs. Dixon and Sencer have not consulted with the Centers for Disease Control and Prevention in the preparation of this Cyberounds® and the opinions expressed and actions proposed are those of the authors.

This activity is made possible by an unrestricted educational grant from .

Release Date: 03/14/2002
Termination Date: 03/14/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Identify and triage patients who may have been exposed to dangerous microbiologic agents, especially agents likely to be used by terrorists
• Guide the collection of critically important information about such patients such as their histories, epidemiologic findings, clinical signs and diagnostic tests
• Find expert sources for assistance in managing the clinical, public health and legal concerns that such patients raise
• Assist in choosing the most appropriate empirical treatments for the patient and his or her contacts.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity